Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3237371
Max Phase: Preclinical
Molecular Formula: C27H28BrClF3N3O3
Molecular Weight: 500.87
Molecule Type: Small molecule
Associated Items:
ID: ALA3237371
Max Phase: Preclinical
Molecular Formula: C27H28BrClF3N3O3
Molecular Weight: 500.87
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: Clc1ccc(-c2cc([C@@H]3CC[C@@H](N4CCOCC4)C[C@H]3c3ccc(Br)cc3)[nH]n2)cc1.O=C(O)C(F)(F)F
Standard InChI: InChI=1S/C25H27BrClN3O.C2HF3O2/c26-19-5-1-17(2-6-19)23-15-21(30-11-13-31-14-12-30)9-10-22(23)25-16-24(28-29-25)18-3-7-20(27)8-4-18;3-2(4,5)1(6)7/h1-8,16,21-23H,9-15H2,(H,28,29);(H,6,7)/t21-,22-,23+;/m1./s1
Standard InChI Key: MYJJTXWMAOBXHS-NGPGEVGDSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 500.87 | Molecular Weight (Monoisotopic): 499.1026 | AlogP: 6.24 | #Rotatable Bonds: 4 |
Polar Surface Area: 41.15 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 1 |
#RO5 Violations: 2 | HBA (Lipinski): 4 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: | CX Basic pKa: 7.86 | CX LogP: 6.16 | CX LogD: 5.58 |
Aromatic Rings: 3 | Heavy Atoms: 31 | QED Weighted: 0.46 | Np Likeness Score: -0.94 |
1. Graham TH, Shu M, Verras A, Chen Q, Garcia-Calvo M, Li X, Lisnock J, Tong X, Tung EC, Wiltsie J, Hale JJ, Pinto S, Shen DM.. (2014) Pyrazoles as non-classical bioisosteres in prolylcarboxypeptidase (PrCP) inhibitors., 24 (7): [PMID:24636945] [10.1016/j.bmcl.2014.02.070] |
Source(1):